Tirapatide (LY3298176) – A Pharmaceutical-Grade Dual Receptor Agonist for Metabolic Research

Product Overview:

Tirapatide (development code: LY3298176) is a breakthrough dual agonist targeting both glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, revolutionizing research in metabolic health and weight management. Unlike single-acting peptides, this pharmaceutical-grade compound simultaneously targets two key metabolic pathways, demonstrating superior efficacy in glycemic regulation and weight loss compared to selective GLP-1 agonists such as dulaglutide. Tirapatide has received clinical approval for the treatment of type 2 diabetes and FDA approval for chronic weight management, becoming a gold standard tool in translational research with broad application prospects in diabetes, obesity, and cardiovascular metabolic disease research.

Tirapatide exhibits a higher affinity for the GIP receptor than the GLP-1 receptor, a unique characteristic that enhances its metabolic effects. By mimicking the endogenous GIP signaling pathway and activating the GLP-1 pathway, this drug offers three synergistic benefits:

• Glucose-dependent insulin secretion: Stimulates insulin release only when blood glucose levels rise, avoiding hypoglycemia—a key safety advantage over non-selective drugs.

• Glucagon inhibition: Reduces inappropriate glucagon secretion, lowering hepatic glucose production and postprandial blood glucose spikes.

• Delayed gastric emptying and appetite regulation: Slows digestion to enhance satiety, reducing calorie intake and supporting sustained weight loss.

*Research and Clinical Applications:

• Type 2 diabetes studies: Demonstrated as monotherapy or adjunctive therapy to improve glycemic control.

• Weight management studies: Clinical trials have shown a 15-20% weight loss (34-48 lbs). This model, combined with diet and exercise, is suitable for adults with a BMI ≥ 30 (or a BMI ≥ 27 with weight-related comorbidities).

• Cardiovascular and metabolic disease research: Investigating its effects on reducing cardiovascular risk factors (hypertension, dyslipidemia) in obese and diabetic individuals.

• Obesity-related comorbidities research: Investigating interventions for non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome.

*Storage and handling guidelines:

*Short-term storage (days to weeks)

• Temperature: 0–4°C (refrigerated)

• Conditions: Sealed container, stored in a dry, dark place; protect from moisture and sunlight.

*Long-term storage (months to years)

• Temperature: -20°C (frozen)

• Stock solution stability: The reconstituted solution can be stored for several months at -20°C or below; avoid repeated freeze-thaw cycles.

Tips to improve solubility:

• Preheat the vial at 37°C for 5–10 minutes before reconstitution.

• Use an ultrasonic bath (avoid vigorous shaking) to improve solubility.

• Prepare fresh working solutions as needed; follow specific solvent selection research protocols.

*Transportation and Logistics:

• Transportation Conditions: Transported at room temperature as a non-hazardous chemical.

• Stability Guarantee: Stable for several weeks during standard transportation and customs clearance.

• Packaging Security: Shockproof and leak-proof packaging with desiccant to maintain dryness.

• Global Delivery: An efficient logistics network covering the US, Europe, South Africa, Nigeria, and other major markets. We use dedicated lines to ensure your goods arrive safely.

• Customs Compliance: Customs clearance success rate exceeding 99%, with professional documentation and extensive export experience.

Why Choose ACDC’s Tesipatide?

1. Industry-Leading R&D Capabilities: Our professional peptide research team is dedicated to innovation in synthetic technology, ensuring batch-to-batch consistency in quality and bioactivity.

2. Scalable Production Capacity: From gram-level samples to ton-level production, our weekly production capacity of 40,000 vials meets diverse research and commercial needs.

3. Advanced Quality Control: Equipped with an advanced quality control system, we possess state-of-the-art laboratories and production equipment and strictly adhere to quality control standards—